N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide

C31H37N5O — CID 172549368

IUPACN-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide
SMILESC[C@]12CC[C@H](NC(=O)N3C=CN=CC3)CC1=CCC1C2CC[C@]2(C)C(n3cnc4ccccc43)=CCC12
InChIInChI=1S/C31H37N5O/c1-30-13-11-22(34-29(37)35-17-15-32-16-18-35)19-21(30)7-8-23-24-9-10-28(31(24,2)14-12-25(23)30)36-20-33-26-5-3-4-6-27(26)36/h3-7,10,15-17,20,22-25H,8-9,11-14,18-19H2,1-2H3,(H,34,37)/t22-,23?,24?,25?,30-,31-/m0/s1
InChIKeyITAJIHZOLSGWOM-MLFHCEEJSA-N
MW495.67 g/mol
LogP6.39
Rot. Bonds2

About N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide

N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide (PubChem CID 172549368) has the molecular formula C31H37N5O and a molecular weight of 495.67 g/mol. Its IUPAC name is N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide.

Molecular Properties

Compound NameN-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide
PubChem CID172549368
Molecular FormulaC31H37N5O
Molecular Weight495.67 g/mol
Exact Mass495.30
IUPAC NameN-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide
SMILESC[C@]12CC[C@H](NC(=O)N3C=CN=CC3)CC1=CCC1C2CC[C@]2(C)C(n3cnc4ccccc43)=CCC12
InChIInChI=1S/C31H37N5O/c1-30-13-11-22(34-29(37)35-17-15-32-16-18-35)19-21(30)7-8-23-24-9-10-28(31(24,2)14-12-25(23)30)36-20-33-26-5-3-4-6-27(26)36/h3-7,10,15-17,20,22-25H,8-9,11-14,18-19H2,1-2H3,(H,34,37)/t22-,23?,24?,25?,30-,31-/m0/s1
InChIKeyITAJIHZOLSGWOM-MLFHCEEJSA-N
XLogP6.39
TPSA62.52 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500495.67
LogP ≤ 56.39
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide?
The IUPAC name of N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide (CID 172549368) is N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide.
What is the SMILES notation for N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide?
The canonical SMILES for N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide is C[C@]12CC[C@H](NC(=O)N3C=CN=CC3)CC1=CCC1C2CC[C@]2(C)C(n3cnc4ccccc43)=CCC12.
What is the InChIKey of N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide?
The InChIKey is ITAJIHZOLSGWOM-MLFHCEEJSA-N. The full InChI is InChI=1S/C31H37N5O/c1-30-13-11-22(34-29(37)35-17-15-32-16-18-35)19-21(30)7-8-23-24-9-10-28(31(24,2)14-12-25(23)30)36-20-33-26-5-3-4-6-27(26)36/h3-7,10,15-17,20,22-25H,8-9,11-14,18-19H2,1-2H3,(H,34,37)/t22-,23?,24?,25?,30-,31-/m0/s1.
What are the key properties of N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide?
N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide has a molecular weight of 495.67 g/mol, XLogP of 6.39, 2 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S,10R,13S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]-2H-pyrazine-1-carboxamide is sourced from PubChem (CID 172549368), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).